venetoclax
abbvie,intensity therapeutics,roche
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'venetoclax', 'intensity thera']
#ash22. after single induction (7+3), for residual disease, lower intensity re-induction (ven/hma) was feasible and comparable to another cycle of 7+3, leading to less time in the hospital, nf and transfusions. mcw experience, but now a widespread practice. 
Leukemia/BMT Doc, dad, steeler fan(atic)